Pediatric Bipolar Disorder Study at UCLA

Examining Neurocognitive Profiles of Bipolar Disorder and Attention-Deficit Hyperactivity Disorder

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00961935

Enrollment

Registered

2009-08-19

Start date

2008-08-31

Completion date

2011-09-30

Last updated

2016-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

bipolar disorder, child bipolar disorder, adolescent bipolar disorder, pediatric bipolar disorder, fMRI, MRI, EEG, neurocognitive tasks

Brief summary

The UCLA Semel Institute for Neuroscience in Los Angeles, CA, is conducting a study looking at similarities and differences in how the brain works between bipolar disorder and attention deficit hyperactivity disorder (ADHD).

Detailed description

Children between the ages of 7 and 17 years old, with a diagnosis of Bipolar I, Bipolar II, or Bipolar NOS, are currently being recruited for this study looking at similarities and differences in how the brain works between bipolar disorder and attention deficit hyperactivity disorder (ADHD). The study involves a comprehensive evaluation at intake, cognitive assessment, EEG, and functional MRI, done over the course of 2 or 3 visits. This study does not provide treatment. However, with participants' consent, the assessment information can be shared with the child's clinician or psychiatrist and a letter with the results from cognitive testing can be prepared, which can be useful in school planning. Referrals for treatment can also be provided.

Interventions

None listed

Study design

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

7 Years to 17 Years

Healthy volunteers

Inclusion criteria

* Subject suffers clinically impairing symptoms of mood lability. * Child has resided with primary caretaker for at least 6 months. * Caretaker speaks sufficient English to complete all study evaluations and measures.

Exclusion criteria

* Lifetime history of mental retardation, autism, or primary diagnosis of psychosis. * Subject is pregnant or nursing.

Countries

United States

Outcome results